Literature DB >> 1900098

Transmission of multidrug-resistant tuberculosis from an HIV-positive client in a residential substance-abuse treatment facility--Michigan.

.   

Abstract

In November 1989, a man with a history of intravenous (IV)-drug use first presented to the tuberculosis (TB) clinic of the Muskegon County (Michigan) Health Department (MCHD). The patient indicated that he had been treated for pulmonary TB in another city, and he produced for clinic staff his labeled medications, which included isoniazid (INH), rifampin (RIF), and ethambutol (EMB). The patient also stated that he was an IV-drug user (IVDU) and previously had tested positive for human immunodeficiency virus (HIV) infection. Sputum specimens for acid-fast bacilli (AFB) were obtained, and the patient was maintained on his anti-TB medications. His HIV-antibody status was confirmed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900098

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  5 in total

1.  The scourge of tuberculosis revisited.

Authors:  J Conly; S Shafran
Journal:  Can J Infect Dis       Date:  1995-11

2.  Mycobacterium tuberculosis: resurgence of an old disease--current problems.

Authors:  V Idemyor
Journal:  J Natl Med Assoc       Date:  1993-02       Impact factor: 1.798

3.  Prospective study of drug-resistant tuberculosis in a Spanish urban population including patients at risk for HIV infection.

Authors:  V Ausina; N Riutort; B Viñado; J M Manterola; J Ruiz Manzano; C Rodrigo; L Matas; M Giménez; J Tor; J Roca
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

Review 4.  New developments in tuberculosis and HIV infection: an opportunity for prevention.

Authors:  J R Curtis; T M Hooton; C M Nolan
Journal:  J Gen Intern Med       Date:  1994-05       Impact factor: 5.128

5.  Frequency of tuberculous and non-tuberculous mycobacteria in HIV infected patients from Bogota, Colombia.

Authors:  M I Murcia-Aranguren; J E Gómez-Marin; F S Alvarado; J G Bustillo; E de Mendivelson; B Gómez; C I León; W A Triana; E A Vargas; E Rodríguez
Journal:  BMC Infect Dis       Date:  2001-11-08       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.